Outcomes for HIV Patients Hospitalized with COVID-19
Study authors compared the presentation characteristics and outcomes of adults with and without HIV who were hospitalized with COVID-19.
HIV/AIDS
Cabotegravir Injection Can Protect Women From HIV for 2 Months
Experimental drug found to be 89% more effective at preventing HIV infection than Truvada.
American College of Physicians Updates Best Practice Advice for Chronic HCV
Based on guidelines issued by the World Health Organizations in 2018, the American College of Physicians has issued best practice advice that simplifies and improves treatment of chronic hepatitis C virus.
HIV, Hepatitis-B Drugs Proven to Reduce Risk of Type 2 Diabetes
Evidence suggests that a class of drugs used to treat HIV and hepatitis B can reduce a patient’s risk for developing type 2 diabetes.
Women Show Higher INSTI-Associated Weight Gain and Incident Diabetes Mellitus Than Men
Study authors investigated whether integrase strand transfer inhibitor treatment was associated with increased weight change from baseline and incident diabetes mellitus.
PrEP Adherence Lower in Cisgender Women Compared to Cisgender Men
Investigators sought to determine PrEP adherence in cisgender women compared to cisgender men, transgender women, transgender men, and non-binary patient populations.
Positive Outlook on Telehealth for HIV care
Study authors investigated patients’ perceptions to utilizing telehealth as an alternative for face-to-face in-person care, hoping to overcome barriers of patient retention such as transportation-related challenges, stigma, and fear of HIV status disclosure.
Risk Factors for Weight Gain Following ART Initiation
Study authors assessed various demographic, HIV-specific, and antiretroviral-therapy-specific risk factors associated with weight gain following initiation of antiretroviral therapy in patients with HIV.
Switching From TDF to TAF or Dual-Therapy Regimens in HIV Patients
Investigators conducted a prospective analysis in patients with HIV to assess the rate of switching from TDF-based to TAF-based or dual therapy regimens and to assess the impact of switching on eGFR.
Well-Controlled HIV Infection Not Associated With Progression of Subclinical Atherosclerosis
A major concern in people with HIV includes accelerated atherosclerosis, underlined by increased rates of coronary artery disease. Researchers investigated the longitudinal progression of atherosclerosis in persons with HIV vs without HIV in the Swiss population.
-
Loading...
-
Loading...
Next post in HIV/AIDS
